CID 3846276

587005-12-7

Structural Information

Molecular Formula
C18H23N7O3S2
SMILES
CC1=CSC(=N1)SCCN2C3=C(N=C2N4CCC(CC4)C(=O)N)N(C(=O)NC3=O)C
InChI
InChI=1S/C18H23N7O3S2/c1-10-9-30-18(20-10)29-8-7-25-12-14(23(2)17(28)22-15(12)27)21-16(25)24-5-3-11(4-6-24)13(19)26/h9,11H,3-8H2,1-2H3,(H2,19,26)(H,22,27,28)
InChIKey
JNTCLIGUCVCYCX-UHFFFAOYSA-N
Compound name
1-[3-methyl-7-[2-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]ethyl]-2,6-dioxopurin-8-yl]piperidine-4-carboxamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

2
References

0
Patents

449.13037 Da
Monoisotopic Mass

1.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 450.13765 201.5
[M+Na]+ 472.11959 212.6
[M-H]- 448.12309 204.7
[M+NH4]+ 467.16419 207.9
[M+K]+ 488.09353 204.5
[M+H-H2O]+ 432.12763 195.0
[M+HCOO]- 494.12857 206.3
[M+CH3COO]- 508.14422 208.8
[M+Na-2H]- 470.10504 195.5
[M]+ 449.12982 205.1
[M]- 449.13092 205.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.